A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Can Antibody-Delivering Drugs Prevent COVID-19 or Hasten Recovery?


The administration of intravenous drugs containing antibodies to the novel coronavirus may be effective in preventing COVID-19 among those at highest risk, such as medical and dental professionals, as well as reducing recovery time and disease severity in those who come down with the infection. In the absence of a vaccine, which would help the body create its own antibodies in response to SARS-CoV-2 exposure, infusion of such antibodies may provide temporary protection from the virus for at least a month. These antibody medications are also under investigation as a treatment for COVID-19. Read more here.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy